fulvestrant has been researched along with epidermal growth factor in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (22.22) | 18.2507 |
| 2000's | 20 (55.56) | 29.6817 |
| 2010's | 7 (19.44) | 24.3611 |
| 2020's | 1 (2.78) | 2.80 |
| Authors | Studies |
|---|---|
| Mellor, SJ; Thomas, EJ | 1 |
| Chatterjee, S; Johnson, DC | 1 |
| Addeo, R; Altucci, L; Battista, T; Bonapace, IM; Bresciani, F; Cancemi, M; Cicatiello, L; Germano, D; Pacilio, C; Salzano, S; Weisz, A | 1 |
| Bonney, RC; Franks, S; Watson, H | 1 |
| Hafner, F; Holler, E; von Angerer, E | 1 |
| Michaelson, CL; Sonnenschein, C; Soto, AM | 1 |
| Damien, E; Lanyon, LE; Price, JS | 1 |
| Codazzi, F; Improta-Brears, T; McDonnell, DP; Meyer, T; Whorton, AR; York, JD | 1 |
| Gehm, BD; Jameson, JL; Jordan, VC; McAndrews, JM | 1 |
| Bland, KI; Filardo, EJ; Frackelton, AR; Quinn, JA | 1 |
| Sampath, D; Winneker, RC; Zhang, Z | 1 |
| Mall, P; Prifti, S; Rabe, T; Strowitzki, T | 1 |
| De Arment, R; Demers, L; Fischer, S; Franks, M; Griffith, J; Leiby, B; Manni, A; Mauger, D; Verderame, M; Washington, S | 1 |
| Gee, JM; Nicholson, RI; Wakeling, AE | 1 |
| Fisher, PA; Flint, AP; Sheldrick, EL | 1 |
| Boester, M; Diedrich, K; Frey, N; Ortmann, O; Porz, S; Treeck, O; Weber, A | 1 |
| Barrow, D; Gee, JM; Harper, ME; Hutcheson, IR; Jordan, N; Knowlden, JM; Madden, TA; McClelland, RA; Nicholson, RI; Wakeling, AE | 1 |
| Iguchi, T; Katsu, Y; Miyagawa, S; Watanabe, H | 1 |
| Kurebayashi, J; Okubo, S; Otsuki, T; Sonoo, H; Tanaka, K; Yamamoto, Y | 1 |
| Mall, P; Prifti, S; Rabe, T | 1 |
| Kurebayashi, J; Okubo, S; Sonoo, H; Yamamoto, Y | 1 |
| Bhatnagar, S; Blankenship, KA; Brey, DM; Keynton, RS; Klinge, CM; Noisin, EL; Risinger, KE; Sumanasekera, WK; Zhao, L | 1 |
| Grandis, JR; Gubish, CT; Lyker, JS; Siegfried, JM; Stabile, LP; Zhang, W | 1 |
| Hershberger, PA; Kanterewicz, B; Land, S; Nichols, M; Siegfried, JM; Vasquez, AC | 1 |
| Bahr, SJ; Pento, JT; Rajah, TT; Tong, GM; Zang, XP | 1 |
| Auricchio, F; Bottero, D; Castoria, G; Ciociola, A; De Falco, A; De Stasio, R; Di Domenico, M; Lombardi, M; Migliaccio, A; Nanayakkara, M; Varricchio, L | 1 |
| Cheng, J; Shapiro, DJ; Yu, DV; Zhou, JH | 1 |
| Bradley, LM; Gierthy, JF; Pentecost, BT | 1 |
| Arita, J; Ishida, M; Izawa, M; Mitsui, T | 1 |
| Badve, S; Bhat-Nakshatri, P; McCune, K; Nakshatri, H; Nephew, KP; Thorat, MA | 1 |
| Kabil, A; Kortenkamp, A; Silva, E | 1 |
| Diaz, MR; Yee, D; Zhang, X | 1 |
| Filardo, EJ; Huang, A; Magruder, HT; Quinn, JA; Reichner, J; Schwartzbauer, JE | 1 |
| Barry, WT; Biagioni, C; Bonechi, M; Brown, M; De Tribolet-Hardy, J; Guarducci, C; Jeselsohn, R; Laing, N; Leo, AD; Malorni, L; Migliaccio, I; Winer, EP; Zhao, J | 1 |
| Avogadri-Connors, F; Cutler, RE; Dowsett, M; Guest, SK; Johnston, SR; Lalani, AS; Martin, LA; Nikitorowicz-Buniak, J; Pancholi, S; Rani, A; Ribas, R; Schuster, E; Simigdala, N; Thornhill, A | 1 |
| Acconcia, F | 1 |
2 review(s) available for fulvestrant and epidermal growth factor
| Article | Year |
|---|---|
Prospects for combining hormonal and nonhormonal growth factor inhibition.
Topics: Antineoplastic Agents; Breast Neoplasms; Drug Therapy, Combination; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gefitinib; Humans; Quinazolines; Tamoxifen | 2001 |
Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Epidermal Growth Factor; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Gefitinib; Gene Expression Regulation; Genes, erbB-1; Humans; Quinazolines; Signal Transduction | 2004 |
1 trial(s) available for fulvestrant and epidermal growth factor
| Article | Year |
|---|---|
TransCONFIRM: Identification of a Genetic Signature of Response to Fulvestrant in Advanced Hormone Receptor-Positive Breast Cancer.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease-Free Survival; Double-Blind Method; Epidermal Growth Factor; Estradiol; Female; Fulvestrant; Gene Expression Profiling; Hepatocyte Nuclear Factor 3-alpha; Humans; Middle Aged; Postmenopause; Receptors, Estrogen; Signal Transduction; Transcription Factor AP-2; Transcriptome | 2016 |
33 other study(ies) available for fulvestrant and epidermal growth factor
| Article | Year |
|---|---|
Interactions between oestradiol and epidermal growth factor in endometrial stromal proliferation and differentiation.
Topics: Blotting, Western; Cell Differentiation; Cell Division; Cells, Cultured; Endometrium; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Leucine; Receptors, Estrogen; Thymidine | 1995 |
Contrasting action of antiestrogen (ICI-182780) for preventing initiation of embryo implantation by estradiol or epidermal growth factor (EGF).
Topics: Animals; Dose-Response Relationship, Drug; Embryo Implantation; Embryo Implantation, Delayed; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hypophysectomy; Male; Models, Biological; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley | 1993 |
Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors.
Topics: Breast Neoplasms; Cell Cycle; Cell Line; DNA, Neoplasm; Enzyme Inhibitors; Epidermal Growth Factor; Estradiol; Estradiol Congeners; Estrogen Antagonists; Female; Fulvestrant; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lovastatin; RNA, Messenger; Simvastatin; Tamoxifen; Tumor Cells, Cultured | 1996 |
Regulation of epidermal growth factor receptor synthesis by ovarian steroids in human endometrial cells in culture.
Topics: Cell Culture Techniques; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Endometrium; Epidermal Growth Factor; ErbB Receptors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gonadal Steroid Hormones; Hormone Antagonists; Humans; Mifepristone; Progesterone; Protein Binding; Stimulation, Chemical | 1996 |
Effect of growth factors on estrogen receptor mediated gene expression.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, Reporter; Growth Substances; HeLa Cells; Humans; Insulin; Insulin-Like Growth Factor I; Luciferases; Receptors, Estrogen; Transfection; Tumor Cells, Cultured; Vitellogenins | 1996 |
Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells.
Topics: Blood Proteins; Breast Neoplasms; Cell Cycle; Cell Division; Chromatography, Affinity; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fibroblast Growth Factor 2; Fulvestrant; Humans; Kinetics; Metribolone; Peptide Fragments; Recombinant Proteins; Serum Albumin; Tumor Cells, Cultured | 1996 |
The estrogen receptor's involvement in osteoblasts' adaptive response to mechanical strain.
Topics: Animals; Bone Remodeling; Cell Division; Down-Regulation; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fibroblast Growth Factor 2; Fulvestrant; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Male; Osteoblasts; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Stress, Mechanical; Tamoxifen | 1998 |
Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium.
Topics: Breast Neoplasms; Calcimycin; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cell Nucleus; Cytoplasm; Egtazic Acid; Enzyme Activation; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; HeLa Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Recombinant Proteins; Tumor Cells, Cultured | 1999 |
EGF activates highly selective estrogen-responsive reporter plasmids by an ER-independent pathway.
Topics: Breast Neoplasms; Cell Division; Epidermal Growth Factor; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Genes, Reporter; Humans; Luciferases; Plasmids; Protein Structure, Tertiary; Receptors, Estrogen; Signal Transduction; Transfection; Tumor Cells, Cultured | 2000 |
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Topics: Breast Neoplasms; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Estradiol; Fulvestrant; Heparin; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Pertussis Toxin; Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Virulence Factors, Bordetella | 2000 |
Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer.
Topics: Adenocarcinoma; Antibodies; Breast Neoplasms; Cell Division; Cysteine-Rich Protein 61; Dactinomycin; DNA, Neoplasm; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation, Neoplastic; Growth Substances; Humans; Immediate-Early Proteins; In Situ Hybridization; Intercellular Signaling Peptides and Proteins; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured | 2001 |
Synthetic estrogens-mediated activation of JNK intracellular signaling molecule.
Topics: Blotting, Western; Cell Differentiation; Cell Division; Enzyme Activation; Epidermal Growth Factor; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Fulvestrant; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Receptors, Estrogen; Signal Transduction; Tumor Cells, Cultured | 2001 |
S-adenosylmethionine decarboxylase overexpression reduces invasiveness and tumorigenicity in nude mice of MCF-7 breast cancer cells.
Topics: Adenosylmethionine Decarboxylase; Agar; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Collagen; DNA-Binding Proteins; Drug Combinations; Epidermal Growth Factor; Estradiol; Female; Fulvestrant; Humans; Laminin; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Proteoglycans; Sensitivity and Specificity; STAT3 Transcription Factor; Tamoxifen; Trans-Activators; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2001 |
Ligand-independent activation of steroid receptors.
Topics: Animals; Butadienes; Cattle; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Endometrium; Enzyme Inhibitors; Epidermal Growth Factor; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression; Humans; Insulin-Like Growth Factor I; Mitogen-Activated Protein Kinases; Nitriles; Receptors, Estrogen; Response Elements; Stromal Cells; Transfection | 2002 |
H-ras dependent estrogenic effects of epidermal growth factor in the estrogen-independent breast cancer cell line MDA-MB-231.
Topics: Breast Neoplasms; Cell Division; Cell Line, Tumor; Epidermal Growth Factor; Estradiol; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Response Elements | 2003 |
The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Division; Cell Line, Tumor; Drug Combinations; Drug Resistance; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gefitinib; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Tamoxifen | 2003 |
Estrogen-independent activation of erbBs signaling and estrogen receptor alpha in the mouse vagina exposed neonatally to diethylstilbestrol.
Topics: Animals; Animals, Newborn; Cell Division; Diethylstilbestrol; Epidermal Growth Factor; Epithelial Cells; ErbB Receptors; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Fulvestrant; Mice; Mice, Inbred C57BL; Phosphorylation; Receptor, ErbB-2; Receptors, Estrogen; Signal Transduction; Vagina | 2004 |
Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Epidermal Growth Factor; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Gefitinib; Humans; Protein-Tyrosine Kinases; Quinazolines; Receptors, Estrogen; Signal Transduction; Tumor Cells, Cultured | 2004 |
Synthetic estrogen-mediated activation of ERK 2 intracellular signaling molecule.
Topics: Blotting, Western; Cell Division; Cells, Cultured; Epidermal Growth Factor; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Fulvestrant; Humans; Mitogen-Activated Protein Kinase 1 | 2003 |
Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Blotting, Western; Cattle; Cell Nucleus; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Epidermal Growth Factor; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Flavonoids; Fulvestrant; Humans; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mice; Microcirculation; Models, Biological; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenols; Phosphorylation; Polyphenols; Resveratrol; Serine; Signal Transduction; Stilbenes; Tamoxifen; Time Factors; Transfection; Umbilical Veins; Wine | 2005 |
Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Growth Processes; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Estradiol; Female; Fulvestrant; Gefitinib; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 3; Quinazolines; Receptors, Estrogen; Xenograft Model Antitumor Assays | 2005 |
Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Epidermal Growth Factor; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Ligands; Lung Neoplasms; Nuclear Receptor Coactivator 2; Receptors, Estrogen; Transcription Factors | 2005 |
Effect of antiestrogens on EGF-mediated movement of human breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cyclopropanes; Epidermal Growth Factor; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Tamoxifen | 2007 |
Crosstalk between EGFR and extranuclear steroid receptors.
Topics: Androgen Receptor Antagonists; Breast Neoplasms; Cell Line, Tumor; Cell Nucleus; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Male; Phosphorylation; Prostatic Neoplasms; Receptor Cross-Talk; Receptors, Androgen; Receptors, Steroid; Signal Transduction; src-Family Kinases; Tyrosine; Up-Regulation | 2006 |
Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.
Topics: Caspase 3; Caspase 9; Cell Death; Enzyme Activation; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Flavonoids; Fulvestrant; HeLa Cells; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Receptors, Estrogen; Tamoxifen; Time Factors | 2007 |
Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Topics: Base Sequence; Breast Neoplasms; Cell Line, Tumor; DNA Primers; Epidermal Growth Factor; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Neoplasms, Hormone-Dependent; Phenotype; Receptor, IGF Type 1; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Signal Transduction; Somatomedins | 2008 |
Absence of ligand-independent transcriptional activation of the estrogen receptor via the estrogen response element in pituitary lactotrophs in primary culture.
Topics: Adenoviridae; Animals; Bromocriptine; Butadienes; Cell Line, Tumor; Cells, Cultured; Colforsin; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Genes, Reporter; Insulin-Like Growth Factor I; Integrases; Isoquinolines; Lactotrophs; Ligands; Luciferases; Nitriles; Pituitary Gland, Anterior; Prolactin; Promoter Regions, Genetic; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Estrogen; Response Elements; Sulfonamides; Thymidine Kinase; Transcriptional Activation; Transduction, Genetic | 2010 |
Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet.
Topics: Breast Neoplasms; Cell Line, Tumor; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Activation; Epidermal Growth Factor; Estradiol; Estrogen Receptor alpha; Fulvestrant; GATA3 Transcription Factor; Gene Regulatory Networks; Hepatocyte Nuclear Factor 3-alpha; Humans; Insulin; Mitogen-Activated Protein Kinases; Neoplasms, Hormone-Dependent; Prognosis; T-Box Domain Proteins; Tamoxifen; Transcription, Genetic | 2010 |
Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens.
Topics: BRCA1 Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; DDT; Dichlorodiphenyl Dichloroethylene; Environmental Pollutants; Enzyme Activation; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Gene Expression Profiling; Hexachlorocyclohexane; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptors, Estrogen; Signal Transduction; src-Family Kinases; Trefoil Factor-1; Tumor Suppressor Proteins | 2010 |
Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Epidermal Growth Factor; ErbB Receptors; Estradiol; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Ligands; MCF-7 Cells; Mitogen-Activated Protein Kinase 3; Phosphorylation; Receptors, Estrogen; RNA Interference; RNA, Messenger; Signal Transduction | 2013 |
The G protein-coupled estrogen receptor-1, GPER-1, promotes fibrillogenesis via a Shc-dependent pathway resulting in anchorage-independent growth.
Topics: Actins; Animals; Benzhydryl Compounds; Breast Neoplasms; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Epidermal Growth Factor; Estradiol; Estrogen Receptor Modulators; Female; Fibronectins; Focal Adhesions; Fulvestrant; Humans; Mice; Mutation; Phenols; Phosphorylation; Receptors, Estrogen; Receptors, G-Protein-Coupled; Shc Signaling Adaptor Proteins; Signal Transduction; Stress Fibers | 2014 |
Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.
Topics: Aromatase Inhibitors; Breast Neoplasms; Cell Proliferation; Epidermal Growth Factor; Estradiol; Estrogen Receptor alpha; Estrogens; Everolimus; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mechanistic Target of Rapamycin Complex 1; Neoplasms, Hormone-Dependent; Quinolines; Receptor, ErbB-2; Receptor, ErbB-3; Signal Transduction; Tamoxifen | 2018 |
Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERĪ± Expressing Breast Cancers.
Topics: Adenosine Triphosphatases; Anastrozole; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Cardiac Glycosides; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Letrozole; MCF-7 Cells; Ouabain; Precision Medicine; Sodium-Potassium-Exchanging ATPase; Tamoxifen | 2022 |